A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/48 (2006.01) A61K 31/4245 (2006.01) A61K 47/10 (2006.01)
Patent
CA 2758847
Pharmaceutical capsule compositions containing the active compound (2R)-2-[[(4- chlorophenyl)sulfonyl][[2-fluo-ro-4-(1,2,4-oxadiazol-3-yl) phenyl]methyl]amino]-5,5,5- trifluoropentanamide, and polyethylene glycol (PEG), Vitamin E polyethylene glycol succinate, polyvinylpryrrolidone (PVP) or copovidone (PVP- Polyvinyl acetate), with or without citric acid, are provided.
L'invention porte sur des compositions de gélules pharmaceutiques contenant le principe actif (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phényl]méthyl]amino]-5,5,5-trifluoropentanamide et du polyéthylène glycol (PEG), du polyéthylène glycol succinate de vitamine E, du polyvinylpyrrolidone (PVP) ou du copovidone (PVP-poly(acétate de vinyle)), avec ou sans acide citrique.
Chandran Sachin
Gandhi Rajesh Babulal
Levons Jaquan Kalani
Perrone Robert Kevin
Price Christopher P.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Bioavailable capsule compositions of amorphous... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioavailable capsule compositions of amorphous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioavailable capsule compositions of amorphous... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2062909